Zimmer Introduces V2F Anterior Fixation System for the Treatment of Spinal Tumor and Trauma Pathology

Mon Jan 21, 2013 4:30pm EST

* Reuters is not responsible for the content in this press release.

For best results when printing this announcement, please click on the link
below:

http://pdf.reuters.com/pdfnews/pdfnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20130121:nPnDE45472

System Incorporates Unique Locking-Cap Technology, Providing Greater Flexibility
in Screw Placement to Better Match Patient Anatomy
MINNEAPOLIS, Minn.,  Jan. 21, 2013  /PRNewswire/ -- Zimmer Holdings, Inc. (NYSE:
ZMH; SIX: ZMH), a global leader in musculoskeletal health, today introduced the
Zimmer  V2F  Anterior Fixation System, a new implant system for the treatment of
thoracolumbar burst fractures, tumors, disc degeneration and other pathologies
of the anterior spine.  The system represents Zimmer's first lateral plate
system for the spinal trauma segment.

The  V2F  System consists of a wide range of plates and screws designed to
better match the varying anatomy of the thoracolumbar spine.  Leveraging a
proprietary technology developed by Zimmer's Trauma business, the  V2F  System
incorporates variable-to-fixed locking cap technology, which enables surgeons to
place screws at variable angles and to lock screw trajectory to the plate
rigidly, or semi-constrained.  This flexibility to place screws with variability
of up to 15 degrees in any direction allows surgeons to avoid critical
anatomical structures and better fit the existing anatomical structure.  

"Tumor and trauma pathology of the spine can result in complex anatomical
challenges for surgeons," said  Steve Healy, President of Zimmer Spine.  "By
incorporating novel variable-to-fixed screw and cap technology, the Zimmer  V2F 
Anterior Fixation System offers surgeons greater flexibility to address the
unique anatomy of every patient through variable screw and plate placement and
fixation."

Designed to facilitate efficiency without compromising control or strength, the
Zimmer  V2F  Anterior Fixation System features All-Through-One Instrumentation
to guide efficient screw placement and 6mm and 7mm dual-lead screws to provide
enhanced insertion speed and bone screw fixation.   

About Zimmer
Founded in 1927 and headquartered in  Warsaw, Indiana, Zimmer designs, develops,
manufactures and markets orthopaedic reconstructive, spinal and trauma devices,
dental implants, and related surgical products.  Zimmer has operations in more
than 25 countries around the world and sells products in more than 100
countries.  Zimmer's 2011 sales were approximately  $4.5 billion.  The Company
is supported by the efforts of more than 8,500 employees worldwide.  For more
information, please visit our website at  www.zimmer.com.

Zimmer Safe Harbor Statement

This press release contains forward-looking statements within the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995 based on
current expectations, estimates, forecasts and projections about the
orthopaedics industry, management's beliefs and assumptions made by management. 
Forward-looking statements may be identified by the use of forward-looking terms
such as "may," "will," "expects," "believes," "anticipates," "plans,"
"estimates," "projects," "assumes," "guides," "targets," "forecasts," and
"seeks" or the negative of such terms or other variations on such terms or
comparable terminology.  These statements are not guarantees of future
performance and involve risks, uncertainties and assumptions that could cause
actual outcomes and results to differ materially.  For a list and description of
such risks and uncertainties, see our periodic reports filed with the U.S.
Securities and Exchange Commission.  We disclaim any intention or obligation to
update or revise any forward-looking statements, whether as a result of new
information, future events or otherwise, except as may be set forth in our
periodic reports.  Readers of this document are cautioned not to place undue
reliance on these forward-looking statements, since, while we believe the
assumptions on which the forward-looking statements are based are reasonable,
there can be no assurance that these forward-looking statements will prove to be
accurate.  This cautionary statement is applicable to all forward-looking
statements contained in this document.

SOURCE  Zimmer Holdings, Inc.


Media: Garry R. Clark, +1-574-372-4493, garry.clark@zimmer.com, or Investors:
Robert J. Marshall Jr., +1-574-371-8042, robert.marshall@zimmer.com

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.